Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Thomas Scanlan
Oregon Health & Science University, Department: Physiology
Should you be removed from our database? Contact us at [email protected]. Read more below.
NeuroVia, Inc.
Other : Technology licensed through our institution (OHSU considers this an SFI)
Please see uploaded pdf
Fatty-acid amide hydrolase targeted prodrugs for directing thyromimetics to the brain
Project Narrative The blood-brain barrier represents a major challenge in developing novel therapeutics for the central nervous system by significantly limiting biodistribution into the brain. There is significant interest in using the thyromimetic sobetirome for treatment in demyelinating disorders such as multiple sclerosis because thyroid hormone is known to regulate the development of oligodendrocytes. By designing prodrugs that target the brain resident protein fatty-acid amide hydrolase (FAAH), this research will test and validate a novel strategy for significantly increasing brain exposure of sobetirome while simultaneously limiting the peripheral effects of this drug.
Filed on May 17, 2018.
Tell us what you know about Thomas Scanlan's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Thomas Scanlan”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Thomas Scanlan | Oregon Health & Science University | Conflict of Interest | NeuroVia, Inc. | Value cannot be readily determined |
| Thomas Scanlan | Oregon Health & Science University | Conflict of Interest | NeuroVia, Inc. | $0 - $4,999 |
| Thomas Scanlan | Oregon Health & Science University | Conflict of Interest | NeuroVia, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.